| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Wilson Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hepatolenticular Degeneration | |||||
| 3 | More general conditions related to this trial | ||||
| Basal Ganglia Diseases | |||||
| Brain Diseases | |||||
| Brain Diseases, Metabolic | |||||
| Brain Diseases, Metabolic, Inborn | |||||
| Central Nervous System Diseases | |||||
| Digestive System Diseases | |||||
| Genetic Diseases, Inborn | |||||
| Heredodegenerative Disorders, Nervous System | |||||
| Liver Diseases | |||||
| Metabolic Diseases | |||||
| Metabolism, Inborn Errors | |||||
| Metal Metabolism, Inborn Errors | |||||
| Movement Disorders | |||||
| Nervous System Diseases | |||||
| Neurodegenerative Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| zinc acetate | |||||
| 5 | Sponsors listed in this trial | ||||
| National Center for Research Resources (NCRR) | |||||
| University of Michigan | |||||
|
